Case study: Shipping media for fresh tissue
For biomarker discovery efforts, primary cell assays, and patient-derived xenograft work, among others, access to fresh human surgical tissue is an essential component in obtaining reliable results.
BioIVT aims to support your research goals by ensuring that the human tissue we provide is in the freshest possible state and closely mimics the function of the in vivo environment.
Fresh tissue must be buffered and sustained with quality media designed to support tissue vitality while minimizing microbial growth during the duration of transit from the collection facility to the researcher’s lab.
Related content from this organisation
- How to block trogocytosis and improve CAR T-cell therapy
- A “hot” issue: TGF -β and checkpoint inhibitor resistance
- Product hub: CD34+ haematopoietic stem cells: One cell type, multiple viable sources
- Whitepaper: Disease state primary cells bring verification and validation studies closer to real-world results
- Whitepaper: Isolation of tumour infiltrating lymphocytes from dissociated tumour cells